Hot Medical Stocks To Buy Right Now

Note that this article refers to the ASX listed NIB Holdings Ltd. and all listed amounts are in AUD unless otherwise noted.

The Stock

NIB Holdings Limited (OTC:NIBHF) is one of Australia’s fastest growing health insurers providing health and medical insurance to over one million Australian and New Zealand residents. NIB also provides private health insurance coverage to over 130,000 international students and workers in Australia and operates Australia’s third largest travel insurer and global distributor, World Nomad’s Group.

Over the last five years, NIB stock has been rising, and the breakout of a recent 5-month consolidation phase has provided an opportunity to enter a long position:

Hot Medical Stocks To Buy Right Now: DigitalGlobe, Inc(DGI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    COPYRIGHT VIOLATION WARNING: “DigitalGlobe (DGI) Earning Somewhat Positive Press Coverage, Report Shows” was published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece on another domain, it was stolen and republished in violation of US & international copyright & trademark laws. The original version of this piece can be read at www.tickerreport.com/banking-finance/3360325/digitalglobe-dgi-earning-somewhat-positive-press-coverage-report-shows.html.

  • [By Scott Rubin]

    Stock gainers included DigitalGlobe (NYSE: DGI), which jumped almost 17 percent on a strong earnings report, and B&G Foods, Inc.(NYSE: BGS) which added 13 percent after its Q2 report. Shares of Western Digital (NASDAQ: WDC) lost more than 11 percent after its quarterly earnings results disappointed Wall Street.

  • [By Lisa Levin]

    In trading on Wednesday, telecommunications services shares rose by just 0.03 percent. Meanwhile, top losers in the sector included Internet Initiative Japan Inc. (ADR) (NASDAQ: IIJI), down 4 percent, and DigitalGlobe Inc (NYSE: DGI), down 2 percent.

Hot Medical Stocks To Buy Right Now: Wins Finance Holdings Inc.(WINS)

Advisors’ Opinion:

  • [By Lisa Levin]

    On Friday, the financial sector proved to be a source of strength for the market. Leading the sector was strength from Wins Finance Holdings Inc (NASDAQ: WINS) and Navient Corp (NASDAQ: NAVI).

  • [By Lisa Levin]

    Friday afternoon, the financial sector proved to be a source of strength for the market. Leading the sector was strength from Wins Finance Holdings Inc (NASDAQ: WINS) and Old Second Bancorp Inc. (NASDAQ: OSBC).

Hot Medical Stocks To Buy Right Now: Cardiome Pharma Corporation(CRME)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Here are some of the media stories that may have impacted Accern’s rankings:

    Get Cardiome Pharma alerts:

    Cardiome Pharma Corp (TSE:COM): Should The Recent Earnings Drop Worry You? (finance.yahoo.com) Pacira Pharmaceuticals Gets a Hold Rating from Canaccord Genuity (analystratings.com) As of May, 21 Analysts See $-0.20 EPS for Cardiome Pharma Corp. (CRME) (thecasualsmart.com) Cardiome Pharma Corp. (CRME) stock added 0.33% off its SMA-20 (thestocksnews.com) Cardiome Pharma (CRME) Upgraded to Sell at ValuEngine (americanbankingnews.com)

    Shares of CRME traded down $0.01 during mid-day trading on Wednesday, reaching $2.29. The company’s stock had a trading volume of 730 shares, compared to its average volume of 138,610. The firm has a market cap of $80.20 million, a price-to-earnings ratio of -2.53 and a beta of 0.19. The company has a debt-to-equity ratio of 2.47, a quick ratio of 3.99 and a current ratio of 4.80. Cardiome Pharma has a 52 week low of $2.28 and a 52 week high of $2.30.

  • [By Lisa Levin]

    Shares of CARDIOME PHARMA CORP (NASDAQ: CRME) were down 43 percent to $3.01. Cardiome priced 10 million shares at $3 per share.

    Seadrill Partners LLC (NYSE: SDLP) was down, falling around 30 percent to $4.09 as the company announced plans to reduce the quarterly cash distribution to $0.10 per unit from $0.25 per unit.

  • [By Lisa Levin]

    Shares of CARDIOME PHARMA CORP (NASDAQ: CRME) were down 30 percent to $2.72 after the company issued U.S. regulatory update for BRINAVESS. The FDA advised Cardiome that the data package proposed is not sufficient to support re-submission of the BRINAVESS NDA.

Hot Medical Stocks To Buy Right Now: Abertis Infraestructuras S.A. (ABFOF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Atlantia (ATASF) (AT.IM), Eiffage (OTCPK:EFGSY) (FGR.FP), Ferrovial (OTC:FRRVF) (FER.SM), Albertis (OTC:ABFOF) (ABE.SM) and Vinci (OTCPK:VCISF) (DG.FP)

Hot Medical Stocks To Buy Right Now: Nu Skin Enterprises Inc.(NUS)

Advisors’ Opinion:

  • [By Roberto Pedone]

    Nu Skin Enterprises (NUS) is a direct selling company, which develops and distributes personal care products and nutritional supplements that are sold under the Nu Skin and Pharmanex brands. This stock closed up 5.4% at $92.96 in Monday’s trading session.

    Monday’s Volume: 2 million

    Three-Month Average Volume: 900,802

    Volume % Change: 85%

    From a technical perspective, NUS ripped higher here right above some near-term support at $85 with heavy upside volume. This move pushed shares of NUS into breakout and new 52-week-high territory, since the stock took out some near-term overhead resistance levels at $88.20 to $89.69. This move also pushed shares of NUS above the upper-end of its recent range that saw the stock trend between $82 to just above $89.

    Traders should now look for long-biased trades in NUS as long as it’s trending above support at $85 and then once it sustains a move or close above Monday’s high of $93.33 with volume that this near or above 900,802 shares. If we get that move soon, then NUS will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $100 to $105.

  • [By Scott Rubin]

    Stock gainers included Mercadolibre Inc (NASDAQ: MELI), up almost 14 percent, and Nu Skin Enterprises, Inc. (NYSE: NUS), which added 12 percent. The positive gains in both stocks were due to strong earnings reports. Shares of Liberty Interactive Group (NASDAQ: QVCA) plunged almost 22 percent on Friday due to disappointing sales growth in its fiscal second quarter. Pharmaceutical giant Bristol-Myers Squibb Co (NYSE: BMY) lost 16 percent after a disappointing study involving its Opdivo drug.

  • [By ]

    Nu Skin Enterprises (NYSE: NUS) is benefiting from two key trends: its strong presence in Asia where it books 79% of its revenue and leading brand awareness with millennials. The company has increased its dividend every year since 2001, now paying a 2% yield, and maintains a share repurchase program that returns excess cash to shareholders.

Leave a Reply

Your email address will not be published. Required fields are marked *